Responding to a recent request for input from the field, the AHA yesterday urged the Center for Medicare and Medicaid Innovation to balance the risk and reward in its alternative payment models “in a way that reflects the significant investments required to launch and maintain APM participation.” It also urged CMMI to “factor implementation periods into any future APMs and reduce mid-model changes to the greatest degree possible,” noting that many AHA members “have indicated they need one to two years to make all the necessary operational, administrative and clinical adjustments to succeed in models.” In addition, AHA urged CMMI to ensure participants “have timely, usable data about their attributed populations,” and “support providers’ ability to deliver accessible, equitable care to patients.” 

Related News Articles

Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…
Headline
The Centers for Medicare & Medicaid Services June 30 issued its calendar year 2026 proposed rule for the home health prospective payment system. This rule…
Headline
The AHA June 27 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee that defends the state’s 340B contract pharmacy law…
Chairperson's File
Public
Advocacy is a core part of the work of the AHA, protecting and sustaining what hospitals and health systems need to truly care for our communities. We often…
Headline
A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services…
Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…